Only qualified healthcare providers may order

Targeted Variant Testing (Copy Number Testing)

This targeted variant test analyzes a patient’s DNA for copy number variants (CNVs) associated with a disease or symptoms of a disease. CNVs are genomic alterations that result in an abnormal number of copies of one or more genes. Certain CNVs have been associated with susceptibility to diseases such as cancer, autoimmune disease, inherited genetic disorders, and more.

This test(s) was developed, and performance characteristics were determined by the HudsonAlpha Clinical Services Lab, LLC. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. These tests are used for clinical purposes, and therefore validation was done as required under the requirements of the Clinical Laboratory Improvement Act (CLIA) of 1988. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The chance of a false negative or a false-positive result due to laboratory error cannot be completely excluded. These results should not be regarded as investigational or for research.